apnimed.com/article/ad109phase3toplineresults

Preview meta tags from the apnimed.com website.

Linked Hostnames

5

Thumbnail

Search Engine Appearance

Google

https://apnimed.com/article/ad109phase3toplineresults

Apnimed Announces Positive Topline Results in the First Landmark Phase 3 Clinical Trial of AD109, an Investigational Once-Daily Oral Pill for Obstructive Sleep Apnea   - Apnimed

Apnimed releases topline Phase 3 landmark results for SynAIRgy clinical trial of AD109, meeting primary endpoint, mean change in apnea-hypopnea index (AHI, p=0.001) at 26 weeks, across all weight classes and a broad range of people with mild, moderate and severe obstructive sleep apnea.



Bing

Apnimed Announces Positive Topline Results in the First Landmark Phase 3 Clinical Trial of AD109, an Investigational Once-Daily Oral Pill for Obstructive Sleep Apnea   - Apnimed

https://apnimed.com/article/ad109phase3toplineresults

Apnimed releases topline Phase 3 landmark results for SynAIRgy clinical trial of AD109, meeting primary endpoint, mean change in apnea-hypopnea index (AHI, p=0.001) at 26 weeks, across all weight classes and a broad range of people with mild, moderate and severe obstructive sleep apnea.



DuckDuckGo

https://apnimed.com/article/ad109phase3toplineresults

Apnimed Announces Positive Topline Results in the First Landmark Phase 3 Clinical Trial of AD109, an Investigational Once-Daily Oral Pill for Obstructive Sleep Apnea   - Apnimed

Apnimed releases topline Phase 3 landmark results for SynAIRgy clinical trial of AD109, meeting primary endpoint, mean change in apnea-hypopnea index (AHI, p=0.001) at 26 weeks, across all weight classes and a broad range of people with mild, moderate and severe obstructive sleep apnea.

  • General Meta Tags

    14
    • title
      Apnimed Announces Positive Topline Results in the First Landmark Phase 3 Clinical Trial of AD109, an Investigational Once-Daily Oral Pill for Obstructive Sleep Apnea   - Apnimed
    • charset
      UTF-8
    • viewport
      width=device-width, initial-scale=1
    • target
      all
    • audience
      all

  • Open Graph Meta Tags

    10
    • US country flagog:locale
      en_US
    • og:type
      article
    • og:title
      Apnimed Announces Positive Topline Results in the First Landmark Phase 3 Clinical Trial of AD109, an Investigational Once-Daily Oral Pill for Obstructive Sleep Apnea   - Apnimed
    • og:description
      Apnimed releases topline Phase 3 landmark results for SynAIRgy clinical trial of AD109, meeting primary endpoint, mean change in apnea-hypopnea index (AHI, p=0.001) at 26 weeks, across all weight classes and a broad range of people with mild, moderate and severe obstructive sleep apnea.
    • og:url
      https://apnimed.com/article/ad109phase3toplineresults/

  • Twitter Meta Tags

    4
    • twitter:card
      summary_large_image
    • twitter:site
      @apnimed
    • twitter:label1
      Est. reading time
    • twitter:data1
      7 minutes

  • Link Tags

    34
    • EditURI
      https://apnimed.com/xmlrpc.php?rsd
    • alternate
      https://apnimed.com/feed/
    • alternate
      https://apnimed.com/comments/feed/
    • alternate
      https://apnimed.com/wp-json/wp/v2/news/1383
    • alternate
      https://apnimed.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fapnimed.com%2Farticle%2Fad109phase3toplineresults%2F

Emails

2

Links

25